BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Dune Medical Devices Ltd. Announces Appointment of Roger Blanchette as Chief Financial Officer


11/23/2011 7:36:32 AM

FRAMINGHAM, Mass., Nov. 23, 2011 /PRNewswire/ -- Dune Medical Devices announced today the appointment of Roger Blanchette as Senior Vice President and Chief Financial Officer, effective immediately. Mr. Blanchette was formerly Executive Vice President and Chief Financial Officer of Cadent, Inc. through Cadent's acquisition by Align Technologies, Inc. in April 2011. In addition, Mr. Blanchette has served in a variety of senior financial management roles prior to his position at Cadent, Inc., including Executive Vice President and Chief Financial Officer of DataSynapse, Inc.

"We are thrilled to have Roger join us at Dune as we continue our introduction of the MarginProbe System in Europe and prepare for widespread commercial introduction in the U.S. Roger's prior experience is an ideal match with Dune today, and considerably strengthens our management team as we approach several critical events in the growth of our company. I look forward to working closely with Roger as we build a strong and sustainable global business," said Dan Levangie, Dune Chief Executive Officer.

About Dune Medical Devices

Dune Medical Devices was founded in 2002 by Dr. Dan Hashimshony to realize the extraordinary medical potential of its proprietary cancer detection technology. Offering surgeons and radiologists the real time ability to identify cancerous tissues and react immediately, this technology holds the promise for a broad range of surgical and diagnostic applications. The MarginProbe System is Dune's first commercial product.

About the MarginProbe System

The MarginProbe System enables real time detection of cancer at or near the surface of excised tissue specimens during surgery for breast cancer. The simple and immediate assessment of the surgical margins allows surgeons to immediately excise additional tissue, potentially saving a second procedure.

Dune Medical Devices is a privately held company financed by Apax Partners. It has offices in the U.S., Israel and Switzerland. For more information, please visit www.dunemedical.com

Contact:
Michael Graffeo
Dune Medical Devices
111 Speen Street
Framingham, MA
(508) 620-2782

SOURCE Dune Medical Devices, Inc.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->